Tumor Lysis Syndrome following a Single Dose of Nivolumab for Relapsed Small-Cell Lung Cancer

Tumor lysis syndrome (TLS) is an oncologic emergency most frequently associated with initial treatment of hematologic malignancies and high-tumor burden solid tumors such as small-cell lung cancer (SCLC). Most often, TLS is associated with cytotoxic chemotherapy. In the treatment of SCLC, a paradigm...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sarah Maryon Hayes, Christine Wiese, Robert Schneidewend
Format: article
Langue:EN
Publié: Karger Publishers 2021
Sujets:
Accès en ligne:https://doaj.org/article/7f3a540ff9c64291a6565598aaa03d70
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!